The acting director of the Office of National Drug Control Policy was among the witnesses at a hearing on efforts to pass legislation reauthorizing that office. Committee members questioned the panelists on which areas of federal drug control efforts were of the most concern, and the direction the Trump administration planned to take in its efforts to combat the national drug trade.

From: C-SPAN

Continue reading about Opioid Epidemic